Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine and new salts
US10933064B2 · kind B2 · utility
1Cited by
3References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 30, 2018 |
| Grant date | Mar 2, 2021 |
| Priority date | — |
| Expiry date | May 30, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application relates to various crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine and salt thereof, as well as compositions and methods of using the same. In some embodiments the crystalline forms also contain water (“hydrates”). These materials are useful in the treatment of various diseases, including carcinomas, specifically lung cancer and more specifically non-small cell lung cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.